Drug Maker Alexion Agrees To Settle SEC Foreign Bribery Probe For ‘Less Than $25M’

(May 7, 2020, 12:59 PM EDT) -- BOSTON — Biopharmaceutical company Alexion Pharmaceuticals Inc. on May 6 told shareholders that on March 30, it reached an agreement in principle with the U.S. Securities and Exchange Commission to settle...
To view the full article, register now.